Genentech forms special committee to “assess” Roche offer(0)
Genentech said today that its board of directors has formed a special committee to “assess” the offer from the Roche Group, its largest shareholder, to acquire all of the outstanding shares of Genentech it doesn’t already own for $89 each, according to a press release the company issued this afternoon.
The committee, made up of the board’s three directors deemed to be independent — and none of the Read the rest of this entry »
Subscribe via RSS all feeds